N/A N=67 TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR
Right Ventricular Dysfunction
Primary: 3D RVEF (Baseline) — 44.71; 48.74; 49.11 percentage — p=0.0167
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=50 TetraGraph in Rocuronium Infusions
Surgery
Primary: Rocuronium Bolus Dose — 0.8 mg/kg
N/A N=49,331 Women's Health Initiative Strong and Healthy Study
Myocardial Infarction · Stroke · Cardiovascular Mortality
Primary: Cardiovascular Events (Composite Myocardial Infarction, Stroke, Cardiovascular Mortality — 5231; 5324 Participants — p=0.49
Phase 4 N=347 Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
Fever After Vaccination · Fever · Seizures Fever
Primary: Number of Participants With Fever Following Vaccination — 14; 10 Participants
Phase 2 N=42 Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma · Grade 1 Follicular Lymphoma · Grade 2 Follicular Lymphoma
Primary: Complete Response (CR) — 38 Participants
Phase 2 N=40 Krill Oil for Pain in Elders
Chronic Musculoskeletal Pain
Primary: Participants With 70% or Greater Adherence Based on Self-reported Daily Diary — 18; 17 Participants
Phase 2 N=95 ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
Primary: Progression-Free Survival (PFS) Rate at 12-months — 9; 11 Participants — p=0.367
N/A N=28 Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes
Diabetes Type 2
Primary: Diff AUC SS0.5 Hyperglycemic — 0.74; 0.96 Pa*hr
N/A N=93 Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID
Long COVID · Pain
Primary: Pain, Enjoyment and General Activity (PEG) — 6.74; 6.74; 8.33; 9.33 Score
N/A N=68 The Impact of a Home-Based Walking Exercise Program on Heart Failure
Heart Failure · Home-based Walking Excercise · Depression
Primary: Depression (Patient Health Questionnaire-9,PHQ-9) — 4.62; 5.21; 2.21; 4.73 points
N/A N=12 Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
Colorectal Cancer
Primary: Number of Participants Completing Colorectal Cancer Screening — 5; 3 Participants
Phase 3 N=750 Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline in Pre-dose Morning First Expiratory Volume in 1 Second (FEV1) in Patients With Chronic Obstructive Pulmonary Disease (COPD) — -0.020; -0.019 liters…
Phase 3 N=588 A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
Depressive Disorder, Major
Primary: Double Blind (DB) Treatment Phase: Change From Baseline to Day 43 in Montgomery- Asberg Depression Rating Scale (MADRS) Total Score- Estimand 1 — -10.5; -12.9 Units on a…
N/A N=40 Intraoperative Echocardiography in Low-Risk CABG Surgery
Heart Diseases · Coronary Artery Disease · Chest Pain
Primary: Enrollment and Randomization Feasibility — 40 Participants
N/A N=200 Comparison of Ultrasound Techniques for Assessment of Endotracheal Tube Placement
Intubation; Difficult or Failed
Primary: Correct Classification of Endotracheal Tube Position — 65; 66; 64 Participants